Conditions: Prostate Cancer
Keywords: castrate resistant
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 18
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the effect of GTx-758 on Serum Prostate-specific antigen (PSA) levels in men with castrate resistant prostate cancer who are maintained on androgen deprivation therapy (Serum PSA response and Serum PSA progression)

Detailed description:

Arms:
arm 1: subjects will receive daily doses of 1000 mg GTx-758

Interventions: intervention 1: GTx-758
Intervention descriptions: intervention 1: two GTx 758 tablets per day

Protocol document: